My name is Jordan Shaw and I have been an investor in the stock market for 20 years. I have a MBA and I am currently a Certified Public Accountant (CPA). Since the age of 16 I have taken a keen interest in the stock market and used my fathers stock account to purchase my own stocks. I am 36 now, and have started this blog to give you my advice on stocks. Most of my information and statistics come from other sources, but using my research I can make suggestions on stocks that have potential.
Buy this pharma stock now
AstraZeneca Plc (NYSE: AZN) is an overlooked stock at a low price right now. Due to a recent drop in first quarter results and the retirement of their CEO AstraZeneca stock has declined. But AstraZeneca has great value. It has a market cap of 58 billion and spends 15% on research and development, which is almost twice the amount of what the average pharmaceutical company spends. It has great healthy balance sheets as well, with lots of cash, about 10 billion. AstraZeneca is a HUGE pharmaceutical company which has a yield of 6%. This makes me feel comfortable with buying this stock and earning good dividends. As of right now AZN trades for about $43 and has a forward P/E ratio of 7. Once the company stabilizes it's revenue stream and takes care of it's top management then a 20% multiple expansion is possible for the future, and not out of the question. This would ultimately bring the share up to 52$ in 12 months which would be a great gain plus dividends.
No comments:
Post a Comment